Mary Jolly
Payments from drug & device makers
Across 89 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$292
- Axsome Therapeutics, Inc.$240
- Novo Nordisk$234
- AstraZeneca$205
- Bayer$113
- Lilly USA, LLC$109
- plus $437 from 15 others
What the payments were for
- Food & beverage$1,630100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $292 |
| Axsome Therapeutics, Inc. | 6 | $240 |
| Novo Nordisk | 14 | $234 |
| AstraZeneca | 6 | $205 |
| Bayer | 6 | $113 |
| Lilly USA, LLC | 8 | $109 |
| Corium, LLC | 9 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Exact Sciences | 2 | $39 |
| AbbVie | 1 | $34 |
| Novartis | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Genentech USA, Inc. | 3 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Pfizer | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,630 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $95,460 |
| FarxigaDapagliflozin Propanediol | 42 | $37,566 |
| EliquisApixaban | 14 | $14,846 |
| JardianceEmpagliflozin | 18 | $13,102 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,992 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $1,095 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,041 |
| Pregabalin | 43 | $996 |
| Insulin Lispro | 14 | $857 |
| Simvastatin | 107 | $842 |
| SynthroidLevothyroxine Sodium | 19 | $829 |
| Atorvastatin Calcium | 71 | $750 |
| Levothyroxine Sodium | 101 | $736 |
| Duloxetine Hcl | 12 | $729 |
| Losartan Potassium | 98 | $696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $234 | $95,46079 claims |
| AstraZenecaFarxiga | $205 | $37,56642 claims |
| PfizerEliquis | $16 | $14,84614 claims |
| Boehringer IngelheimJardiance | $14 | $13,10218 claims |
| Lilly USA, LLCInsulin Lispro | $109 | $85714 claims |
| AbbVieSynthroid | $34 | $82919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.
Other family in Cadiz
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.